Molecular characterisation of individual tumours, such as the association between EGFR (epidermal growth factor receptor) and radio-resistance [52,53] is likely to play an important role in the near future to determine the aggressiveness of disease and the best outcomes from a variety of treatment options. Here, EGFR is linked to neoplasm.